Todd C. Skaar

Also affiliated with Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, Indiana University

Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and PharmaceuticsEconomics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 37 papers. Top paper: “Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators”.

Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators

Clinical and Translational Science(2022)10.1111/cts.13376

N/A

0.650DataRank · unranked

22 citations

Emily J. Cicali, Kristin Wiisanen, Roger B. Fillingim, Hrishikesh Chakraborty, Rachel A. Myers +35 more

Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network

Genetics in Medicine(2021)10.1038/s41436-021-01118-9

N/A

0.529DataRank · unranked

33 citations

Larisa H. Cavallari, Hrishikesh Chakraborty, Rhonda M. Cooper‐DeHoff, Paul Dexter, Michael T. Eadon +51 more

Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106813

N/A

0.487DataRank · unranked

10 citations

Kerri L. Cavanaugh, Lori A. Orlando, David Christian, Hrishikesh Chakraborty, Kady-Ann Steen-Burrell +30 more

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2137

N/A

0.330DataRank · unranked

8 citations

Opeyemi A. Jegede, Victor T. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand +15 more

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07519-z

N/A

0.174DataRank · unranked

2 citations

Anne O’Neill, Bryan P. Schneider, Todd C. Skaar, Minetta C. Liu, Caroline Lohrisch +9 more

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

Clinical and Translational Science(2021)10.1111/cts.13154

N/A

0DataRank · unranked

30 citations

Ramzi G. Salloum, Amanda L. Elchynski, D. Max Smith, Elizabeth J. Rowe, Kathryn Blake +24 more

Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network

Journal of Personalized Medicine(2021)10.3390/jpm11070647

N/A

0DataRank · unranked

27 citations

Olivia M Dong, Megan C. Roberts, Paul Dexter, Amanda R. Elsey, Geoffrey S. Ginsburg +11 more

Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study

Kidney360(2021)10.34067/kid.0005362021

N/A

0DataRank · unranked

20 citations

Judith Maddatu, Sharon M. Moe, Arjun Sinha, Ricardo Melo Ferreira, Brent W. Miller +7 more

Mapping the miRNA‐mRNA Interactome in Human Hepatocytes and Identification of Functional mirSNPs in Pharmacogenes

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2379

N/A

0DataRank · unranked

13 citations

Harrison Zhao, Joseph Ipe, Yunlong Liu, Todd C. Skaar, Nicholas R. Powell

Prospective validation of genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12003

N/A

0DataRank · unranked

2 citations

Opeyemi A. Jegede, Victor T. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand +15 more

Quantification of Spatial Pharmacogene Expression Heterogeneity in Breast Tumors

Research Square(2021)10.21203/rs.3.rs-1043506/v1

N/A

0DataRank · unranked

1 citations

Rebecca Silvola, John S. Howard, Sunil Badve, Todd C. Skaar, Joseph Ipe +1 more

Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing

Journal of Molecular Diagnostics(2022)10.1016/j.jmoldx.2022.03.008

N/A

0DataRank · unranked

17 citations

Tyler Shugg, Ryan Ratcliff, Wilberforce Osei, Ty C. Lynnes, Victoria M. Pratt +9 more

Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report

Frontiers in Oncology(2022)10.3389/fonc.2021.809527

N/A

0DataRank · unranked

14 citations

Tyler Shugg, Reynold C. Ly, Costantine Albany, Milan Radovich, Bryan P. Schneider +2 more

Evaluation of Potential Racial Disparities inCYP2C19‐Guided P2Y12Inhibitor Prescribing After Percutaneous Coronary Intervention

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2776

N/A

0DataRank · unranked

10 citations

Nita A. Limdi, Amber L. Beitelshees, James C. Lee, Julio D. Duarte, Francesco Franchi +17 more

Quantification of spatial pharmacogene expression heterogeneity in breast tumors

Cancer Reports(2022)10.1002/cnr2.1686

N/A

0DataRank · unranked

9 citations

Rebecca Silvola, John S. Howard, Sunil Badve, Todd C. Skaar, Joseph Ipe +1 more

Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms

Research Square(2022)10.21203/rs.3.rs-1315678/v1

N/A

0DataRank · unranked

5 citations

Julie A. Douglas, Robert M. Miller, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta +7 more

Clinically Important Alterations in Pharmacogene Expression in Histologically Severe Nonalcoholic Fatty Liver Disease

Research Square(2022)10.21203/rs.3.rs-1878803/v1

N/A

0DataRank · unranked

4 citations

Tiebing Liang, Joseph Ipe, Sha Cao, Todd C. Skaar, Zeruesenay Desta +6 more

The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial

The Pharmacogenomics Journal(2023)10.1038/s41397-023-00315-w

N/A

0DataRank · unranked

15 citations

Marc B. Rosenman, Pengyue Zhang, Cathy R. Fulton, John T. Callaghan, Ann Holmes +16 more

Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease

Nature Communications(2023)10.1038/s41467-023-37209-1

N/A

0DataRank · unranked

42 citations

Tiebing Liang, Joseph Ipe, Sha Cao, Todd C. Skaar, Zeruesenay Desta +6 more

Cytochrome P450 Oxidoreductase ( POR ) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2431

N/A

0DataRank · unranked

5 citations

Guanglong Jiang, Santosh Philips, Laura Gardner, Gloria Xue, Erica Cantor +10 more

Analysis of the combined effect of rs699 and rs5051 on angiotensinogen expression and hypertension

Chronic Diseases and Translational Medicine(2023)10.1002/cdt3.103

N/A

0DataRank · unranked

2 citations

Tyler Shugg, Jacob Leighty, Matthew Martin, Rolf P. Kreutz, Michael T. Eadon +4 more

Analysis of the Combined Effect of rs699 and rs5051 on Angiotensinogen Expression and Hypertension

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.07.536073

N/A

0DataRank · unranked

3 citations

Tyler Shugg, Jacob Leighty, Matthew Martin, Rolf P. Kreutz, Michael T. Eadon +4 more

Data from Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

(2023)10.1158/1078-0432.c.6523959

N/A

0DataRank · unranked

0 citations

Amanda L. Blackford, Anne Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich +12 more

288 CFTR genetic variants and association with cancer

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01215-8

N/A

0DataRank · unranked

0 citations

Tyler Shugg, Nicholas R. Powell, Todd C. Skaar, Steven R. Bray, Cynthia D. Brown +1 more

The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation

Pharmacogenetics and Genomics(2024)10.1097/fpc.0000000000000547

N/A

0DataRank · unranked

21 citations

J. Kevin Hicks, Jai N. Patel, Amanda L. Elchynski, D. Max Smith, Salma A. Bargal +43 more

Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3402

N/A

0DataRank · unranked

14 citations

Emma M. Tillman, Amy M. Breman, Jennelle C. Hodge, C. McDonald, Reynold C. Ly +10 more

Functional analysis of G6PD variants associated with low G6PD activity in the All of Us Research Program

Genetics(2024)10.1093/genetics/iyae170

N/A

0DataRank · unranked

2 citations

Renee C. Geck, Dongbing Lai, Tyler Shugg, Todd C. Skaar, Maitreya J. Dunham +1 more

Functional Analysis of G6PD Variants Associated With Low G6PD Activity in the All of Us Research Program

medRxiv(2024)10.1101/2024.04.12.24305393

N/A

0DataRank · unranked

0 citations

Renee C. Geck, Dongbing Lai, Tyler Shugg, Todd C. Skaar, Maitreya J. Dunham +1 more

Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine Therapy

Clinical and Translational Science(2025)10.1111/cts.70466

N/A

0DataRank · unranked

3 citations

Christina L. Aquilante, Salma A. Bargal, Larisa H. Cavallari, Julio D. Duarte, Kelly Gunderson +12 more

Assessing patient understanding of pharmacogenomic test results: a qualitative study

Pharmacogenomics(2025)10.1080/14622416.2025.2560292

N/A

0DataRank · unranked

2 citations

Samantha L. Vershaw, Karen Schmidt, Todd C. Skaar, Peter H. Schwartz, Tom A. Doyle

Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3545

N/A

0DataRank · unranked

2 citations

Tayler B. Smith, John T. Callaghan, Wilberforce Osei, Steven M. Bray, Emma M. Tillman +6 more

Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial

Frontiers in Genetics(2020)10.3389/fgene.2020.00571

N/A

0DataRank · unranked

8 citations

Kenneth D. Levy, Yong Zang, Ann Holmes, Christa L. Stoughton, Paul Dexter +2 more

Pharmacogenetics of steady-state metabolism, pharmacokinetics, and adverse effects of voriconazole in healthy participants

Drug Metabolism and Disposition(2025)10.1016/j.dmd.2025.100156

N/A

0DataRank · unranked

2 citations

Ayşe Gelal, Chisook Moon, Ingrid F. Metzger, Jessica Bo Li Lu, John T. Callaghan +3 more

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data

The Pharmacogenomics Journal(2020)10.1038/s41397-020-0162-5

N/A

0DataRank · unranked

46 citations

Larisa H. Cavallari, Craig R. Lee, William B. Hillegass, Ann Holmes, Todd C. Skaar +14 more

The Access Technology Program of the Indiana Clinical Translational Sciences Institute (CTSI): A model to facilitate access to cutting-edge technologies across a state

Journal of Clinical and Translational Science(2020)10.1017/cts.2020.525

N/A

0DataRank · unranked

1 citations

Todd C. Skaar, Melanie E. DeFord, Joel A. Ybe, Julie Driscol, Christine Drury +11 more

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2149

N/A

0DataRank · unranked

408 citations

Andrew A. Monte, Rachel Huddart, Kelly E. Caudle, Evan D. Kharasch, Andrea Gaedigk +16 more

Opportunity for Genotype‐Guided Prescribing Among Adult Patients in 11 US Health Systems

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2161

N/A

0DataRank · unranked

60 citations

Nihal El Rouby, Henry H. Ong, Jonathan S. Schildcrout, Laura B. Ramsey, Yaping Shi +23 more